1h Free Analyst Time
The rapid plasma reagin test market is forecasted to grow by USD 66.6 million during 2023-2028, accelerating at a CAGR of 5.87% during the forecast period. The report on the rapid plasma reagin test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of syphilis, adoption of serological tests by blood banks, and rising uptake of RPR in antenatal clinics (ANCS).
The rapid plasma reagin test market is segmented as below:
By Test
- Rapid plasma reagin test kits
- Analyzers and instruments
- Reagents
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the rapid plasma reagin test market covers the following areas:
- Rapid plasma reagin test market sizing
- Rapid plasma reagin test market forecast
- Rapid plasma reagin test market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Test
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global rapid plasma reagin test market: Abbott Laboratories, Anamol Laboratories Pvt. Ltd., ARKRAY Inc., Arlington Scientific Inc., Atlas Medical GmbH, Becton Dickinson and Co., Bio RAD Laboratories Inc., Cardinal Health Inc., F. Hoffmann La Roche Ltd., Innovatek Medical Inc., Lorne Laboratories Ltd., Mediclone Biotech, Newmarket Biomedical Ltd., Novacyt SA, Sclavo Diagnostics International S.r.l., Sekisui Chemical Co. Ltd., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is automated RPR systems."
According to the report, one of the major drivers for this market is the increasing incidence of syphilis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Anamol Laboratories Pvt. Ltd.
- ARKRAY Inc.
- Arlington Scientific Inc.
- Atlas Medical GmbH
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Cardinal Health Inc.
- F. Hoffmann La Roche Ltd.
- Innovatek Medical Inc.
- Lorne Laboratories Ltd.
- Mediclone Biotech
- Newmarket Biomedical Ltd.
- Novacyt SA
- Sclavo Diagnostics International S.r.l.
- Sekisui Chemical Co. Ltd.
- Thermo Fisher Scientific Inc.
